MALIGNANT MELANOMA STAGE 0

MALIGNANT MELANOMA STAGE 0 was reported 209 times

These drug classes are most commonly taken by patients reporting MALIGNANT MELANOMA STAGE 0:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 97
1 Corticosteroid [EPC] 95
2 Aminosalicylate [EPC] 71
3 Proton Pump Inhibitor [EPC] 71
4 Serotonin-3 Receptor Antagonist [EPC] 66
5 HMG-CoA Reductase Inhibitor [EPC] 64
6 Osmotic Laxative [EPC] 60
7 Vitamin D3 Analog [EPC] 57
8 Erythropoiesis-stimulating Agent [EPC] 55
9 Angiotensin Converting Enzyme Inhibitor [EPC] 54
10 Insulin Analog [EPC] 53
11 Vitamin C [EPC] 53
12 Stimulant Laxative [EPC] 51
13 Nitroimidazole Antimicrobial [EPC] 50
14 Xanthine Oxidase Inhibitor [EPC] 49
15 Vitamin K [EPC] 47
16 Warfarin Reversal Agent [EPC] 47
17 Nitrate Vasodilator [EPC] 44
18 Osmotic Diuretic [EPC] 44
19 Azole Antifungal [EPC] 41
20 Calcium Channel Blocker [EPC] 41
21 Dihydropyridine Calcium Channel Blocker [EPC] 41
22 Potassium Salt [EPC] 41
23 Interleukin-5 Antagonist [EPC] 40
24 Arteriolar Vasodilator [EPC] 39
25 Calcium [EPC] 34
26 Vitamin B12 [EPC] 34
27 Vitamin D [EPC] 34
28 Fluoroquinolone Antibacterial [EPC] 28
29 Platelet Aggregation Inhibitor [EPC] 28
30 Parenteral Iron Replacement [EPC] 27
31 Tetracycline-class Drug [EPC] 27
32 Antidote [EPC] 25
33 Antidote for Acetaminophen Overdose [EPC] 25
34 Mucolytic [EPC] 25
35 Provitamin D2 Compound [EPC] 25
36 Catecholamine [EPC] 22
37 Standardized Chemical Allergen [EPC] 22
38 Phosphodiesterase 5 Inhibitor [EPC] 21
39 Anti-IgE [EPC] 18
40 5-alpha Reductase Inhibitor [EPC] 17
41 Methylxanthine [EPC] 14
42 Sphingosine 1-phosphate Receptor Modulator [EPC] 14
43 Amide Local Anesthetic [EPC] 13
44 Antiarrhythmic [EPC] 13
45 CD20-directed Cytolytic Antibody [EPC] 13
46 Ester Local Anesthetic [EPC] 13
47 Non-Standardized Chemical Allergen [EPC] 13
48 Tumor Necrosis Factor Blocker [EPC] 13
49 Atypical Antipsychotic [EPC] 12
50 Folate Analog Metabolic Inhibitor [EPC] 12
51 Bismuth [EPC] 11
52 Angiotensin 2 Receptor Blocker [EPC] 10
53 Integrin Receptor Antagonist [EPC] 10
54 Polyene Antimicrobial [EPC] 9
55 Alkaloid [EPC] 8
56 CD52-directed Cytolytic Antibody [EPC] 8
57 Leukotriene Receptor Antagonist [EPC] 8
58 Janus Kinase Inhibitor [EPC] 7
59 Interleukin-23 Antagonist [EPC] 6
60 Thalidomide Analog [EPC] 4
61 Interleukin-13 Antagonist [EPC] 3
62 Interleukin-17A Antagonist [EPC] 3
63 Interleukin-4 Receptor alpha Antagonist [EPC] 3
64 Proteasome Inhibitor [EPC] 3
65 Thiazide Diuretic [EPC] 3
66 Dietary Cholesterol Absorption Inhibitor [EPC] 2
67 Epidermal Growth Factor Receptor Antagonist [EPC] 2
68 Interleukin-31 Receptor alpha Antagonist [EPC] 2
69 Kinase Inhibitor [EPC] 2
70 Opioid Agonist [EPC] 2
71 Androgen [EPC] 1
72 Antirheumatic Agent [EPC] 1
73 Aromatase Inhibitor [EPC] 1
74 Benzodiazepine [EPC] 1
75 Carnitine Analog [EPC] 1
76 Central Nervous System Stimulant [EPC] 1
77 Complement Inhibitor [EPC] 1
78 Copper-containing Intrauterine Device [EPC] 1
79 GLP-1 Receptor Agonist [EPC] 1
80 GLP-2 Analog [EPC] 1
81 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
82 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
83 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
84 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
85 Histamine-1 Receptor Antagonist [EPC] 1
86 Histamine-2 Receptor Antagonist [EPC] 1
87 Insulin [EPC] 1
88 Interleukin-12 Antagonist [EPC] 1
89 Methylating Agent [EPC] 1
90 Nitrofuran Antibacterial [EPC] 1
91 Non-narcotic Antitussive [EPC] 1
92 PCSK9 Inhibitor [EPC] 1
93 Pediculicide [EPC] 1
94 Phosphodiesterase 4 Inhibitor [EPC] 1
95 Prostacycline Vasodilator [EPC] 1
96 Prostaglandin Analog [EPC] 1
97 Purine Antimetabolite [EPC] 1
98 beta3-Adrenergic Agonist [EPC] 1